{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:49:37Z","timestamp":1793915377406,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41587-025-02624-w","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T06:36:03Z","timestamp":1743402963000},"page":"454-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models"],"prefix":"10.1038","volume":"44","author":[{"given":"Xin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Nan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-8327","authenticated-orcid":false,"given":"Chu-Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-7473","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-0305","authenticated-orcid":false,"given":"Ling-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"2624_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"2624_CR2","doi-asserted-by":"publisher","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer\u2019s disease: the challenge of the second century. Sci. Transl. Med. 3, 77sr71 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2624_CR3","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.3233\/JAD-179921","volume":"64","author":"CX Gong","year":"2018","unstructured":"Gong, C. X., Liu, F. & Iqbal, K. Multifactorial hypothesis and multi-targets for Alzheimer\u2019s disease. J. Alzheimers Dis. 64, S107\u2013s117 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"2624_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","volume":"138","author":"A De Roeck","year":"2019","unstructured":"De Roeck, A., Van Broeckhoven, C. & Sleegers, K. The role of ABCA7 in Alzheimer\u2019s disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathol. 138, 201\u2013220 (2019).","journal-title":"Acta Neuropathol."},{"key":"2624_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","volume":"6","author":"K Iqbal","year":"2010","unstructured":"Iqbal, K. & Grundke-Iqbal, I. Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement. 6, 420\u2013424 (2010).","journal-title":"Alzheimers Dement."},{"key":"2624_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner, F. L., Ransohoff, R. M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358\u2013372 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"2624_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306 (2019).","journal-title":"Cell Rep."},{"key":"2624_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines9050524","volume":"9","author":"IG Onyango","year":"2021","unstructured":"Onyango, I. G. et al. Neuroinflammation in Alzheimer\u2019s disease. Biomedicines 9, 524 (2021).","journal-title":"Biomedicines"},{"key":"2624_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157\u2013172 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"2624_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-180098","volume":"63","author":"Z Cai","year":"2018","unstructured":"Cai, Z. et al. Role of blood\u2013brain barrier in Alzheimer\u2019s disease. J. Alzheimers Dis. 63, 1223\u20131234 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"2624_CR11","doi-asserted-by":"publisher","first-page":"9180","DOI":"10.1073\/pnas.2002571117","volume":"117","author":"AR Rezai","year":"2020","unstructured":"Rezai, A. R. et al. Noninvasive hippocampal blood\u2013brain barrier opening in Alzheimer\u2019s disease with focused ultrasound. Proc. Natl Acad. Sci. USA 117, 9180\u20139182 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2624_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12465","volume":"10","author":"J Cummings","year":"2024","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2024. Alzheimers Dement. (N. Y.) 10, e12465 (2024).","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"2624_CR13","doi-asserted-by":"publisher","first-page":"pe47","DOI":"10.1126\/scisignal.2003511","volume":"5","author":"R Kang","year":"2012","unstructured":"Kang, R. & Tang, D. PKR-dependent inflammatory signals. Sci. Signal. 5, pe47 (2012).","journal-title":"Sci. Signal."},{"key":"2624_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0338-3","volume":"10","author":"KD Hwang","year":"2017","unstructured":"Hwang, K. D., Bak, M. S., Kim, S. J., Rhee, S. & Lee, Y. S. Restoring synaptic plasticity and memory in mouse models of Alzheimer\u2019s disease by PKR inhibition. Mol. Brain 10, 57 (2017).","journal-title":"Mol. Brain"},{"key":"2624_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/jpet.121.000590","volume":"378","author":"M Lopez-Grancha","year":"2021","unstructured":"Lopez-Grancha, M. et al. A novel selective PKR inhibitor restores cognitive deficits and neurodegeneration in Alzheimer disease experimental models. J. Pharmacol. Exp. Ther. 378, 262\u2013275 (2021).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2624_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12887","volume":"18","author":"M Tible","year":"2019","unstructured":"Tible, M. et al. PKR knockout in the 5xFAD model of Alzheimer\u2019s disease reveals beneficial effects on spatial memory and brain lesions. Aging Cell 18, e12887 (2019).","journal-title":"Aging Cell"},{"key":"2624_CR17","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cell.2011.11.029","volume":"147","author":"PJ Zhu","year":"2011","unstructured":"Zhu, P. J. et al. Suppression of PKR promotes network excitability and enhanced cognition by interferon-\u03b3-mediated disinhibition. Cell 147, 1384\u20131396 (2011).","journal-title":"Cell"},{"key":"2624_CR18","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1111\/j.1460-9568.2008.06491.x","volume":"28","author":"HM Chen","year":"2008","unstructured":"Chen, H. M., Wang, L. & D\u2019Mello, S. R. A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. Eur. J. Neurosci. 28, 2003\u20132016 (2008).","journal-title":"Eur. J. Neurosci."},{"key":"2624_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","volume":"177","author":"CX Liu","year":"2019","unstructured":"Liu, C. X. et al. Structure and degradation of circular RNAs regulate PKR activation in innate immunity. Cell 177, 865\u2013880 (2019).","journal-title":"Cell"},{"key":"2624_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.molcel.2021.11.019","volume":"82","author":"CX Liu","year":"2022","unstructured":"Liu, C. X. et al. RNA circles with minimized immunogenicity as potent PKR inhibitors. Mol. Cell 82, 420\u2013434 (2022).","journal-title":"Mol. Cell"},{"key":"2624_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41587-024-02204-4","volume":"43","author":"S-K Guo","year":"2025","unstructured":"Guo, S.-K. et al. Therapeutic application of circular RNA aptamers in a mouse model of psoriasis. Nat. Biotechnol. 43, 236\u2013246 (2025).","journal-title":"Nat. Biotechnol."},{"key":"2624_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13195-017-0308-0","volume":"9","author":"J Hugon","year":"2017","unstructured":"Hugon, J., Mouton-Liger, F., Dumurgier, J. & Paquet, C. PKR involvement in Alzheimer\u2019s disease. Alzheimers Res. Ther. 9, 83 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"2624_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0969-9961(03)00086-X","volume":"14","author":"A Peel","year":"2003","unstructured":"Peel, A. Activation of the cell stress kinase PKR in Alzheimer\u2019s disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 14, 52\u201362 (2003).","journal-title":"Neurobiol. Dis."},{"key":"2624_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd.2016.39","volume":"15","author":"JN Fullerton","year":"2016","unstructured":"Fullerton, J. N. & Gilroy, D. W. Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug Discov. 15, 551\u2013567 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2624_CR25","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"2624_CR26","doi-asserted-by":"publisher","first-page":"117957351770927","DOI":"10.1177\/1179573517709278","volume":"9","author":"R Chang","year":"2017","unstructured":"Chang, R., Yee, K. L. & Sumbria, R. K. Tumor necrosis factor \u03b1 inhibition for Alzheimer\u2019s disease. J. Cent. Nerv. Syst. Dis. 9, 1179573517709278 (2017).","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"2624_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-23","volume":"9","author":"K Belarbi","year":"2012","unstructured":"Belarbi, K. et al. TNF-\u03b1 protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J. Neuroinflammation 9, 23 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2624_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0006-291X(03)01318-4","volume":"308","author":"NV Jammi","year":"2003","unstructured":"Jammi, N. V., Whitby, L. R. & Beal, P. A. Small molecule inhibitors of the RNA-dependent protein kinase. Biochem. Biophys. Res. Commun. 308, 50\u201357 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2624_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","volume":"159","author":"XO Zhang","year":"2014","unstructured":"Zhang, X. O. et al. Complementary sequence-mediated exon circularization. Cell 159, 134\u2013147 (2014).","journal-title":"Cell"},{"key":"2624_CR30","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"2624_CR31","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman, S. E., Allison, E. K. & El Khoury, J. Microglial dysfunction and defective \u03b2-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J. Neurosci. 28, 8354\u20138360 (2008).","journal-title":"J. Neurosci."},{"key":"2624_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg, E. E. et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain 139, 1265\u20131281 (2016).","journal-title":"Brain"},{"key":"2624_CR33","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1002\/cpns.81","volume":"89","author":"A Myers","year":"2019","unstructured":"Myers, A. & McGonigle, P. Overview of transgenic mouse models for Alzheimer\u2019s disease. Curr. Protoc. Neurosci. 89, e81 (2019).","journal-title":"Curr. Protoc. Neurosci."},{"key":"2624_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bpa.12883","volume":"31","author":"L Reimer","year":"2021","unstructured":"Reimer, L. et al. PKR kinase directly regulates Tau expression and Alzheimer\u2019s disease-related Tau phosphorylation. Brain Pathol. 31, 103\u2013119 (2021).","journal-title":"Brain Pathol."},{"key":"2624_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C. et al. Alzheimer\u2019s disease. Lancet 377, 1019\u20131031 (2011).","journal-title":"Lancet"},{"key":"2624_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz, C. & Mayeux, R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640\u2013651 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"2624_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","volume":"33","author":"R Kimura","year":"2009","unstructured":"Kimura, R. & Ohno, M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5xFAD Alzheimer mouse model. Neurobiol. Dis. 33, 229\u2013235 (2009).","journal-title":"Neurobiol. Dis."},{"key":"2624_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0167-5273(02)00554-5","volume":"90","author":"G Vassalli","year":"2003","unstructured":"Vassalli, G., Bueler, H., Dudler, J., von Segesser, L. K. & Kappenberger, L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int. J. Cardiol. 90, 229\u2013238 (2003).","journal-title":"Int. J. Cardiol."},{"key":"2624_CR39","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41587-023-02047-5","volume":"42","author":"N Zabaleta","year":"2024","unstructured":"Zabaleta, N. & Gil-Farina, I. Tracing the fate of AAV vectors in the body. Nat. Biotechnol. 42, 1183\u20131184 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2624_CR40","doi-asserted-by":"publisher","first-page":"1051559","DOI":"10.3389\/fneur.2022.1051559","volume":"13","author":"BS Hollidge","year":"2022","unstructured":"Hollidge, B. S. et al. Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors. Front. Neurol. 13, 1051559 (2022).","journal-title":"Front. Neurol."},{"key":"2624_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jalz.2017.08.012","volume":"14","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer\u2019s disease. Alzheimers Dement. 14, 215\u2013229 (2018).","journal-title":"Alzheimers Dement."},{"key":"2624_CR42","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","volume":"19","author":"R Lin","year":"2022","unstructured":"Lin, R. et al. Directed evolution of adeno-associated virus for efficient gene delivery to microglia. Nat. Methods 19, 976\u2013985 (2022).","journal-title":"Nat. Methods"},{"key":"2624_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d\u2019Errico","year":"2022","unstructured":"d\u2019Errico, P. et al. Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue. Nat. Neurosci. 25, 20\u201325 (2022).","journal-title":"Nat. Neurosci."},{"key":"2624_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"C-H Chen","year":"2012","unstructured":"Chen, C.-H. et al. Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int. J. Neuropsychopharmacolog. 15, 77\u201390 (2012).","journal-title":"Int. J. Neuropsychopharmacolog."},{"key":"2624_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1750-3639.2011.00520.x","volume":"22","author":"C Paquet","year":"2012","unstructured":"Paquet, C. et al. The PKR activator PACT is induced by A\u03b2: involvement in Alzheimer\u2019s disease. Brain Pathol. 22, 219\u2013229 (2012).","journal-title":"Brain Pathol."},{"key":"2624_CR46","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1582-4934.2009.00849.x","volume":"13","author":"M Morel","year":"2009","unstructured":"Morel, M., Couturier, J., Lafay-Chebassier, C., Paccalin, M. & Page, G. PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer\u2019s disease. J. Cell. Mol. Med. 13, 1476\u20131488 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"2624_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0733-8619(03)00070-7","volume":"20","author":"JR Zunt","year":"2002","unstructured":"Zunt, J. R. Central nervous system infection during immunosuppression. Neurol. Clin. 20, 1\u201322 (2002).","journal-title":"Neurol. Clin."},{"key":"2624_CR48","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.rdc.2017.06.009","volume":"43","author":"MJ Bradshaw","year":"2017","unstructured":"Bradshaw, M. J., Cho, T. A. & Chow, F. C. Central nervous system infections associated with immunosuppressive therapy for rheumatic disease. Rheum. Dis. Clin. North Am. 43, 607\u2013619 (2017).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"2624_CR49","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees, C. V. & Williams, M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848\u2013858 (2006).","journal-title":"Nat. Protoc."},{"key":"2624_CR50","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"2624_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"2624_CR52","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2624_CR53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"2624_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"}],"updated-by":[{"DOI":"10.1038\/s41587-026-03281-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000}}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02624-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02624-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02624-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:42:09Z","timestamp":1786603329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02624-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1038\/s41587-025-02624-w","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"1 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41587-026-03281-3","URL":"https:\/\/doi.org\/10.1038\/s41587-026-03281-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.-L.C., X.F. and C.-X.L. are named as inventors on patents related to circRNA aptamers held by the CEMCS, CAS. L.-L.C. is a scientific cofounder of RiboX Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}